Voting rights: Epigenomics AG: Publication pursuant to §26 sect.1 WpHG (the German Securities Trading Act) with the aim of pan-European distribution

Epigenomics AG / Voting rights: Voting Rights: Release of a Voting
Rights Notification (§ 21 para. 1
WpHG) in Accordance with § 26, para. 1 WpHG (German Securities
Trading Act) with the Aim of an Europe-wide Distribution

Publication pursuant to §26 sect.1 WpHG (the German Securities
Trading Act) processed and transmitted by Hugin. The issuer is solely
responsible for the content of this announcement.

----------------------------------------------------------------------
--------------

Issuer:

Epigenomics AG
- ISIN DE000A0BVT96 -
Kleine Präsidentenstr. 1
10178 Berlin
Deutschland

Voting Rights Notification:

On 10 September 2008 Federated Investors Inc., Pittsburgh, PA, USA
made the following notifications regarding the holding of voting
rights held in Epigenomics AG, Berlin, Germany, according to § 21
WpHG in their name as well as for Federated Equity Management Company
of Pennsylvania, Pittsburgh, PA, USA:

Notification of voting rights in the name and on behalf of Federated
Equity Management Company of Pennsylvania pursuant to § 21 para. 1
WpHG:

On 8 September 2008 Federated Equity Management Company of
Pennsylvania exceed the 20 per cent threshold of § 21 para. 1 WpHG
and held at this date 20.125 per cent of the voting rights (5,375,319
voting rights) in Epigenomics AG.

As of 8 September 2008 Federated Equity Management Company of
Pennsylvania held 20.125 per cent of the voting rights (5.375.319
voting rights) in Epigenomics AG. All 20.125 per cent of the voting
rights (5.375.319 voting rights) are attributed to Federated Equity
Management Company of Pennsylvania pursuant to § 22 para. 1 sent. 1
no. 6 WpHG. Some of the voting rights are attributed to Federated
Equity Management Company of Pennsylvania by Federated Kaufmann Fund
which holds directly 3 per cent or more of the voting rights in
Epigenomics AG.

Federated Investors Inc. are the parent company of F II Holdings
Inc., which in turn is the parent company of Federated Equity
Management Company of Pennsylvania. Federated Equity Management
Company of Pennsylvania, an investment adviser registered in the
United States under the Investment Company Act of 1940, acts as
Investment Adviser to the Federated Kaufmann Fund and Federated
Kaufmann Fund II, both Massachusetts Business Trusts and Investment
Companies, as that term is defined under the Investment Company Act
1940, as amended.

Date of release: 11. September 2008

Epigenomics AG
The Executive Board

Contact:
Epigenomics AG
Dr. Achim Plum
Sr. Vice President Corporate Development
Tel.: +49 (0)30 24345 368
Fax: +49 (0)30 24345 555
Email: achim.plum@epigenomics.com

--- End of Message ---

Epigenomics AG
Kleine Präsidentenstr.1 Berlin Germany

WKN: A0BVT9;
ISIN: DE000A0BVT96; Index: CDAX, Prime All Share, TECH All Share;
Listed: Amtlicher Markt in Frankfurter Wertpapierbörse, Prime
Standard in Frankfurter Wertpapierbörse,
Freiverkehr in Börse Berlin, Freiverkehr in Börse Düsseldorf,
Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr
in Bayerische Börse München,
Freiverkehr in Börse Stuttgart;
Copyright © Hugin AS 2008. All rights reserved.